tara

tara
LA Mayor's Office Acknowledges the NDF's Advocacy with GNEM

Wednesday, February 24, 2016

Calling all European GNE Myopathy Patients For A Networking Event In France


Dr Anthony Behin and his colleagues from Lyon, France, would like to invite European GNE Myopathy patients and patient advocacy groups for an informal networking event:

Date of Event: March 16, 2016
Time of Event: 12 noon to 4.00 p.m.
Place of Event: Lyon, France

The purpose of this event is to bring patient advocacy groups and patients together to provide an update on the work they are doing, to network, and to connect with doctors and other GNE Myopathy patients.

This meeting is supported by a grant from Ultragenyx Pharmaceutical company that is conducting clinical trials using Sialic Acid.

   Here  is an outline of the meeting topics:
   Overview of GNEM
·       Prevalence of GNEM worldwide              
·       Patient Advocacy Support for GNEM
·       Current Resources for GNEM patients
·       Networking

I encourage any GNE Myopathy patients living in Europe to attend.  Please contact Dr. Behin if you need additional information and are interested in applying for a travel stipend, his email is  Anthony.behin@aphp.fr,


In addition, a patient with a neuromuscular disease who uses a wheelchair has offered to assist those who are attending this event, and need information regarding accessible travel and other logistics. Please contact her at:  maryze@pacesworld.com

Below is a sample of the registration form.

WEDNESDAY 16TH MARCH 2016FROM 12 NOON - 4 PM
NAME:

INSTITUTION/ORGANISATION:

ADDRESS:

TELEPHONE:

EMAIL:

ADDITIONAL COMMENTS:








Saturday, February 20, 2016

A Moment in a Day of a Rare Disease Patient: "I Don't Want To Be An Inspiration Today"

Friends,
Kam, is a GNE Myopathy patient who depicts her challenges with this very disabling disease through her unique and very touching illustrations. All of Kam's drawings are inspired from her actual life including the progression of this extremely rare and debilitating muscle disease that took over her body at age 21. She went from kicking soccer balls and running to making use of canes, leg braces and now a wheelchair. This disease will keep going until it seizes every ounce of her body.  
Recently, one of her illustrations was selected by Rare Artist, a division of Everylife Foundation to be displayed during Rare Disease Caucus Week (Feb. 29-Mar. 3) on Capitol Hill in Washington, D.C.

My name is Kam Redlawsk and I am 14 years into this disease known as HIBM (GNE Myopathy). I am an Industrial Designer and an Illustrator. Five years ago I began using art to draw moments of everyday struggles and triumphs of HIBM. It was an attempt to expand my awareness advocacy for HIBM and to invite people to observe a small window of the intimate moments of living with such a rare and ultimately extremely debilitating condition. 
'I Don't Want to Be an Inspiration Today' is an illustration of a particular day, of a particular moment. One day when I was home alone I fell, like I so often used to do when I was still walking. My only option was to lay on the floor while I waited for help, and as I laid there feeling utterly alone I noticed the sun as it projected the shadow of the window upon me. At this time I was still walking - utilizing leg braces and a cane to assist my weakening and wobbly legs. And, in that moment, and moments like it, I felt the intimate and most personal expression that most people outside my helping circle never see. I see a lot of disabled public speaker's speak on how to be positive, how to keep going, which I think is very important, but rarely do I see them show the true side of what it is like living with a life altering disability and/or struggle. And I understand why, because it really is difficult to share your weaknesses. But I think this glazes over what disability is truly like and for outsiders it's a shallow perception of what “being strong” means. 
With all the advocacy work I used to do, more in the past then today, I would have genuine moments of frustration in being the “positive” figure and despite trying to move ahead and spread awareness what I was really thinking was, “I don't want to be an inspiration today, I just don't have it in me to make sure everyone else is ok with my disability”. I didn't want to be the one showing all this vulnerability so people could tell me what an inspiration I was, even though logically I understand why people say that. Because I say the same to others. But the times when people told me what an inspiration I was and then walk away and forget my disease and cause, I felt frustrated and alone. If people only saw the depths of the struggle in every single day, every single second, every single moment then they would have a broader understanding and empathy towards such a rare disease and try to help conquer it. I don't want to be an inspiration, I only want to get rid of this condition.
When I drew this I was struggling to continue walking and doing my best to not to succumb to the inevitable wheelchair in hopes that I would still be walking when human trials would come around. I never made it. I eventually gave into a wheelchair right before trials began. Today my legs are not only near paraplegic but HIBM has begun its work on my upper extremities. My arms, shoulders, fingers, hands and neck will fall to the same plight my legs have if treatment does not come soon.
Most all of my illustrations are built around HIBM. You can view more at: https://www.facebook.com/KamRedlawsk/

Friday, February 12, 2016

Rare Disease Day Events Around The World, Registry,Recruitment And Gene Editing Technologies



February 29 th. 2016, will be the ninth annual Rare Disease Day that will be observed around the world. There are over 7,000  rare diseases, and communities around the world will be conducting various events to bring attention to the plight of patients living with these rare diseases.  Our hope is to raise awareness and improve access to treatment both for patients and their families. I would like to give  a great big "shout out" to Team India (World Without GNE Myopathy,India) for coming up with an essay contest to raise awareness among the youth population.
Here are some of the events that have been scheduled.

Canada:               http://www.rarediseaseday.org/association/4
India:                    http://www.rarediseaseday.org/event/india/975
Israel:                   http://www.rarediseaseday.org/country/il/israel
United States:      https://ncats.nih.gov/rdd
                             http://rareadvocates.org/rdw/
Here is a more comprehensive  link to a map that includes specific events in respective countries around the world: http://www.rarediseaseday.org/events/world:
Reminders:
Registry for GNE Myopathy Patients:
Previously, I know that some patients may have had difficulty understanding all the information/questions regarding giving "consent" to the Registry, as it was printed only in English. Currently information about what is collected in the Registry have been translated in eight other languages to give you a better understanding.  Please register if you haven't registered already. See link below
http://www.treat-nmd.eu/gne/patient-registries/international-registry/

**What is a patient registry and why do we want to create one?
"When a clinical study or trial is being planned, it is very important that patients suitable for that trial can be found and contacted quickly. A registry is like a bridge connecting patients and families with doctors and researchers who are trying to understand and treat the disease by making sure that patients’ details are all collected in a single database or “registry”. TREAT-NMD network and Ultragenyx Pharmaceutical are creating this international registry for people from different countries who have HIBM".
**Ref. from treat-nmd. registry's site.

Many Sites Are Still Recruiting Patients For Sialic Acid Phase 3
https://clinicaltrials.gov/ct2/show/NCT02377921?term=gne+myopathy&rank=4

Gene Editing (from GNE-Myopathy International Site)
Gene editing means changing the DNA sequence of an organism (such as human) in situ, that is, within a living organism. This technology has the potential to change any sequence (like a mutation) in a patient’s DNA and convert it back into the normal sequence . Several types of gene editing methods have been developed in the last decade.   For more information, please refer to:  http://gne-myopathy.org/research.html